174 related articles for article (PubMed ID: 12945223)
1. [Clinical significant of serum chromogranin A levels for diagnosing pheochromocytoma in hypertensive patients].
Biausque F; Jaboureck O; Devos P; D'Herbomez M; Hainaut P; Carré A; Mounier-Vehier C
Arch Mal Coeur Vaiss; 2003; 96(7-8):780-3. PubMed ID: 12945223
[TBL] [Abstract][Full Text] [Related]
2. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan.
Giovanella L; Squin N; Ghelfo A; Ceriani L
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):344-7. PubMed ID: 17043632
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
[TBL] [Abstract][Full Text] [Related]
5. The role of chromogranin A in the management of patients with phaeochromocytoma.
Grossrubatscher E; Dalino P; Vignati F; Gambacorta M; Pugliese R; Boniardi M; Rossetti O; Marocchi A; Bertuzzi M; Loli P
Clin Endocrinol (Oxf); 2006 Sep; 65(3):287-93. PubMed ID: 16918946
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction.
Canale MP; Bravo EL
J Clin Endocrinol Metab; 1994 May; 78(5):1139-44. PubMed ID: 8175970
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of elevated serum chromogranin A levels.
Syversen U; Ramstad H; Gamme K; Qvigstad G; Falkmer S; Waldum HL
Scand J Gastroenterol; 2004 Oct; 39(10):969-73. PubMed ID: 15513336
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas.
Abou-Saif A; Gibril F; Ojeaburu JV; Bashir S; Entsuah LK; Asgharian B; Jensen RT
Cancer; 2003 Jul; 98(2):249-61. PubMed ID: 12872342
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor 1, chromogranin A and prostate specific antigen serum levels in prostate cancer patients and controls.
Marszalek M; Wachter J; Ponholzer A; Leitha T; Rauchenwald M; Madersbacher S
Eur Urol; 2005 Jul; 48(1):34-9. PubMed ID: 15967249
[TBL] [Abstract][Full Text] [Related]
11. Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin A.
Sciarra A; Voria G; Monti S; Mazzone L; Mariotti G; Pozza M; D'Eramo G; Silverio FD
Prostate; 2004 Mar; 58(4):421-8. PubMed ID: 14968443
[TBL] [Abstract][Full Text] [Related]
12. Serum chromogranin-alpha immunoradiometric assay in the diagnosis of pheochromocytoma.
Giovanella L; Ceriani L
Int J Biol Markers; 2002; 17(2):130-4. PubMed ID: 12113580
[TBL] [Abstract][Full Text] [Related]
13. [Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients].
Leibovitch I; Pinthus Y; Sella BA; Ramon J
Harefuah; 2006 Jan; 145(1):25-9, 78. PubMed ID: 16450720
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
Stridsberg M; Husebye ES
Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129
[TBL] [Abstract][Full Text] [Related]
15. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.
Berruti A; Mosca A; Tucci M; Terrone C; Torta M; Tarabuzzi R; Russo L; Cracco C; Bollito E; Scarpa RM; Angeli A; Dogliotti L
Endocr Relat Cancer; 2005 Mar; 12(1):109-17. PubMed ID: 15788643
[TBL] [Abstract][Full Text] [Related]
16. Serum chromogranin-A assay in differential diagnosis of incidentally discovered adrenal masses.
Giovanella L
Anticancer Res; 2005; 25(3A):1547-50. PubMed ID: 16033058
[TBL] [Abstract][Full Text] [Related]
17. Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.
Woltering EA; Hilton RS; Zolfoghary CM; Thomson J; Zietz S; Go VL; Vinik AI; Vinik E; O'Dorisio TM; Mamikunian G
Pancreas; 2006 Oct; 33(3):250-4. PubMed ID: 17003646
[TBL] [Abstract][Full Text] [Related]
18. Circulating chromogranin A as a diagnostic tool in clinical chemistry.
O'Connor DT; Takiyyuddin MA; Cervenka JH; Parmer RJ; Barbosa JA; Chang YM; Hsiao RJ
Acta Histochem Suppl; 1990; 38():27-33. PubMed ID: 2080246
[TBL] [Abstract][Full Text] [Related]
19. Measurements of chromogranin B can serve as a complement to chromogranin A.
Stridsberg M; Eriksson B; Fellström B; Kristiansson G; Tiensuu Janson E
Regul Pept; 2007 Mar; 139(1-3):80-3. PubMed ID: 17116339
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of tumor M2-pyruvate kinase in neuroendocrine tumors. A comparative study with chromogranin A.
Pezzilli R; Migliori M; Morselli-Labate AM; Campana D; Ventrucci M; Tomassetti P; Corinaldesi R
Anticancer Res; 2003; 23(3C):2969-72. PubMed ID: 12926146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
